Castle Biosciences CSTL Finance Lease, Principal Payments
Finance Lease, Principal Payments at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's finance lease, principal payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Castle Biosciences's finance lease, principal payments?
- Castle Biosciences (CSTL) reported finance lease, principal payments of $24K in Q1 2026.
- How has Castle Biosciences's finance lease, principal payments changed year-over-year?
- Castle Biosciences's finance lease, principal payments decreased by 7.7% year-over-year, from $26K to $24K.
- What is the long-term trend for Castle Biosciences's finance lease, principal payments?
- Over 4 years (2021 to 2025), Castle Biosciences's finance lease, principal payments has grown at a 94.7% compound annual growth rate (CAGR), from $8K to $115K.